A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife System for the Ablation of Unresectable Stage 3 Pancreatic Adenocarcinoma

Study Title
A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife® System for the Ablation of Unresectable Stage 3 Pancreatic Adenocarcinoma
Sponsor Name
Angiodynamics, Inc.
NCT Number
NCT03899636
IDE Number
G180278
CMS Approval Date
2019-05-03
Category
B

https://clinicaltrials.gov/ct2/show/NCT03899636